Opinion on Pharmaceuticals and Healthcare

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Expert View
Expert View

Waste not, want not: drug delivery to the rescue

Published By Datamonitor
22 Sep 2000
CommentWire
CommentWire

Cell Pathways: FDA rejection could spell trouble

Published By Datamonitor
25 Sep 2000
CommentWire
CommentWire

Scotia: Foscan falters at the final hurdle

Published By Datamonitor
27 Sep 2000
CommentWire
CommentWire

Pfizer strikes in the battle for the US Alzheimer's market

Published By Datamonitor
28 Sep 2000
CommentWire
CommentWire

DuPont / Kos Pharmaceuticals: a good combination for dyslipidemia

Published By Datamonitor
28 Sep 2000
Expert View
Expert View

Making the most of new indications

Published By Datamonitor
29 Sep 2000
CommentWire
CommentWire

Pharmaceuticals: reaching a web audience

Published By Datamonitor
29 Sep 2000
CommentWire
CommentWire

Bristol-Myers Squibb: divesting to grow

Published By Datamonitor
02 Oct 2000
CommentWire
CommentWire

Serono: fertile market for Ovidrel

Published By Datamonitor
03 Oct 2000
CommentWire
CommentWire

UCB: winning European market with novel anti-epileptic?

Published By Datamonitor
05 Oct 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.